GlobeNewswire Inc.·Mar 27·NaQuantum BioPharma Grants 35,000 Stock Options to Retain TalentQuantum BioPharma grants 35,000 stock options to employees at CA$6.50 strike, vesting immediately with five-year exercise window. QNTMclinical trialbiopharmaceutical
GlobeNewswire Inc.·Mar 11·NaQuantum BioPharma Adjusts Debenture Terms Amid Share Price DeclineQuantum BioPharma revises debenture offering terms following share price decline, lowering conversion price to $3.00 and increasing warrant allocation. QNTMwarrantsbiopharmaceutical
GlobeNewswire Inc.·Mar 10·NaQuantum BioPharma Launches $4M Convertible Offering to Fund OperationsQuantum BioPharma raises capital through convertible debentures and debt-to-equity conversion to strengthen balance sheet and fund business development. QNTMprivate placementcapital raising